| Accession Number | 0001193125-26-256013 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 3, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jun 1, 2026 | Exercise/Conversion | 25,000 | $8.27 | $206,750.00 | 33,977 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jun 1, 2026 | Sale | 21,069 | $70.11 | $1,477,080.17 | 12,908 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jun 1, 2026 | Sale | 3,931 | $70.75 | $278,103.31 | 8,977 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jun 1, 2026 | Grant/Award | 615 | $70.44 | $43,320.60 | 9,592 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jun 1, 2026 | Grant/Award | 615 | $0.00 | $0.00 | 10,207 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Common Stock | โ | Jun 2, 2026 | Tax Withholding | 452 | $70.44 | $31,838.88 | 9,755 | Direct | โ | View Details | |
President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission. | Stock option (right to buy) | Derivative | Jun 1, 2026 | Exercise/Conversion | 25,000 | $0.00 | $0.00 | 141,986 | Direct | โ | View Details |